Phase 3 Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have already completed a previous related trial (study 218224 or 221672) up to and including the Week 52 visit, without being considered a "treatment failure."
- If you have the skin condition SSc, you must have an area of skin on your abdomen or upper thigh that is unaffected or only mildly affected, so that an injection under the skin can be given there.
- You must be able and willing to give yourself the study medication by injection, or have a caregiver or healthcare professional who can do this for you throughout the trial.
- If you are a woman who could become pregnant, you must not currently be pregnant or breastfeeding, and you must use a highly effective form of contraception (less than 1% failure rate) during the trial and for at least 4 months after your last dose.
- If you are a woman who could become pregnant, you must have a negative pregnancy test within 24 hours before your first dose of the study medication.
- You must be willing and able to give your informed consent, meaning you understand and agree to follow all the trial's requirements.
Who may not be able to join:
- If you stopped taking the study medication before the Week 52 visit in the previous related trial, you would not be eligible.
- If you have developed a significant, unstable, or uncontrolled serious illness unrelated to your underlying condition (such as heart, lung, blood, digestive, liver, kidney, nerve, cancer, or infection problems) that could put you at unnecessary risk, you may not be eligible.
- If you have developed any other medical conditions, abnormal lab results, or other issues (such as poor vein access) that could affect how the medication works in your body, make it unsafe for you to continue, or make it hard to interpret the trial results, you may not be eligible.
- If you have been exposed to more than a certain level of radiation (above 10 millisieverts over background) in the past 3 years — through work or previous research studies — you may not be eligible.
- If a specific heart rhythm measurement (called the QTc interval) taken at your Week 52 visit in the previous trial was above a certain level (480 milliseconds), you may not be eligible (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: GSK Clinical Trials, GlaxoSmithKline
Phone: 877-379-3718
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with Adverse events (AEs), Adverse Event of Special Interest events (AESIs), and Serious Adverse Event (SAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.